• <nav id="e44oi"><code id="e44oi"></code></nav>
    <xmp id="e44oi">
  • Home About Us Resource News & Events Sites
    Building Blocks

    Our Team

    Founder & Co-founder

    • Minmin Yang, PhD

      FOUNDER, CHAIRMAN

      ?  PhD/Postdoctoral at Auburn University

      ?  Served at Roche Palo Alto and Roche China, with increasing responsibilities from group leader to section head of medicinal chemistry

      ?  80 articles and patents, including 16 international patents

    • Xihan Wu, PhD

      Co-Founder

      ?  PhD at Shanghai Institute of Materia Medica, Chinese Academy of Sciences

      ?  Postdoctoral at University of Michigan

      ?  Served at Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and as section head at Roche China R&D Center

      ?  50 articles and patents, including 33 international patents


    • Shuhai Zhao, PhD

      CO-FOUNDER, CHIEF SCIENTIFIC OFFIER

      ?  PhD at University of Paris-Sud

      ?  Postdoctoral at Massachusetts Institute of Technology

      ?  Served at Hoechst-Celanese, Roche US/China R&D Center

      ?  Led 5 project teams and discovered 7 clinical candidates, 3 of which have entered clinical trials and 2 were advanced into phase II. 

      ?  Contributed to the invention of FanaptTM

      ?  70 articles and patents, including 25 international patents


    Core Team

    • Wenfang Miao, PhD

      Chief Executive Officer

      ?  PhD at Texas Christian University

      ?  Served as VP of Analytical Services for WuXi AppTec , Senior VP of Quality and Regulatory and VP of Analytical Chemistry for Pharmaron, Senior Manager of Analytical Chemistry for Elan Drug Delivery and Principle Scientist for GSK Drug Development

      ?  20+ years experience in analytical R&D, quality control, quality assurance, CMC development and regulatory compliance


    • Xudong Wei, PhD

      Senior Vice President,Head of CDMO Business

      ? PhD at Nanjing University

      ? Postdoc at Tübingen, York and Emory 

      ? API leader, 15 yr at Boehringer-Ingelheim 

      ? VP at Pharmaron

      ? 20+ years experience in drug substance development & manufacturing

      ? 80+ articles, 16 patents


    • Shijie Zhang, PhD

      Chief Technology Officer

      ?  PhD at Emory University

      ?  Served as Director of Process Chemistry and API Production at Agios, USA

      ?  Successfully advanced 2 compounds from preclinical to commercial, 2 to Phase III, 1 to Phase II

      ?  40+ articles and patents


    • Jing Li, PhD

      President of PharmaBlock (USA), Inc., Senior Vice President

      ?  PhD at Nanjing University

      ?  Postdoctoral at Southwestern Medical Center, Dallas, USA

      ?  Served at Cumbre, Millennium, Cubist, Merck

      ?  18+ years experience in new drug research and development and process development

      ?  40 articles and patents, including 18 international patents


    • Yuanping Jie, PhD

      Vice President

      ?  PhD at Auburn University

      ?  Served as VP of Shanghai Huayi Group Technology Research Institute

      ?  20+ years of R&D and production experience

      ?  15+ articles, 16 patents


    • Yuanming Zhu, PhD

      Vice President

      ?  PhD at Duquesne University

      ?  Postdoctoral at Colorado State University

      ?  Served as head of Adama China R&D Center

      ?  20+ years of R&D experience

      ?  40 patents, 39 of which are authorized patents


    • Ke Zhao, PhD

      Vice President

      ?  PhD at University of Mississippi

      ?  20+ years experience in drug formulation development

      ?  Served at Ancheng Pharmaceutical, Anbisheng and Yangzijiang Pharmaceutical

      ?  Developed 12 FDA-approved products including 6 global first imitations; successfully challenged and evaded more than 100 formulation patents


    • Liu Liu, PhD

      Vice President

      ?  PhD at Bowling Green State University

      ?  Postdoctoral at the University of Pennsylvania

      ?  Served at Rogel Cancer Center and led the discovery of multiple small molecule targeted anti-cancer drugs with new chemical structures, 5 of which are in clinical trials at different stages

      ?  50+ articles and patents, including 10+ international patents


    • Jingwei Zhu, PhD

      Vice President

      ?  PhD at Beijing Institute of Technology

      ?  10+ years of R&D management experience, throughout process R&D, analytical chemistry, supply chain management and production

      ?  10+ articles and patents


    • Hui Li, PhD

      Vice President

      ?  PhD atThe University of Texas at Austin

      ?  Postdoctoral at Colorado State University

      ?  Served as Director/VP of R&D of Anichem Suzhou

      ?  20+ years of experience in synthetic organic chemistry


    • Yi Li

      Vice President

      ?  Master at Nankai University

      ?  MBA at Maastricht School of Management (MSM)

      ?  Served at Roche China R&D Center

      ?  15+ years of R&D and management experience

    • Minyue Zhang

      President of PharmaBlock Pharmaceuticals (Shandong) Co., Ltd.

      ?  Graduated from Zhengzhou University

      ?  Served as Deputy General Manager of Ouyi Pharmaceutical, a subsidiary of CSPC

      ?  26+ years of production management experience


    • Yifei Wu

      Vice President

      ?  Worked at Jiangsu Tianheng Certified Public Accountants; Deloitte Touche Tohmatsu Certified Public Accountants

      ?  Served as CFO of Simcere Pharmaceutical Group; CFO of Eft Intelligent Equipment Co., Ltd.

      ?  20+ years of financial management experience


    ? 成人视频免费在线观看 - 视频 - 在线观看 - 影视资讯 -心晴网